Medical Equipment

Self-Injections Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Single-Photon Emission Computed Tomography (SPECT) Market Growth Performance Trended Historically, And What Lies Ahead?

The market size of Single-photon emission computed tomography (SPECT) has seen considerable growth in the past few years. The projection for this market is to increase from a sum of $2.37 billion in 2024 to about $2.5 billion in 2025, marking a compound annual growth rate (CAGR) of 5.7%. Factors like increasing requirement for diagnostic imaging, the escalating rate of chronic diseases, breakthroughs in radiopharmaceuticals, a growing elderly population, and mounting healthcare expenditures have contributed to the historical growth.

Anticipated to experience substantial expansion in the forthcoming years, the market size of single-photon emission computed tomography (SPECT) is projected to escalate to $3.57 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.3%. Factors fuelling this booming growth during the forecast period include an increased focus on precision medicine, wider applications in the field of neurological imaging, a global surge in cancer rates, progression in radiotracer development, and its inclusion in multimodal imaging systems. Predominant trends to watch out for within the forecast period encompass improved image reconstruction methods, the advent of mobile SPECT imaging services, a heightened focus on cardiac imaging, advancements in detector technology, and a rise in clinical research initiatives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Single-Photon Emission Computed Tomography (SPECT) Market?

An increase in the instances of cancer is forecasted to stimulate an upward trend in the single-photon emission computed tomography (SPECT) market. This escalation in cancer patients comes from an aging demographic, unhealthy lifestyle practices, and environmental constituents. Single-photon emission computed tomography (SPECT) plays a vital role in diagnosing, classifying, and observing cancers in conjunction with other imaging techniques such as computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. For instance, the World Health Organization, an agency of the United Nations situated in Switzerland, reported in September 2023 that there were 41 million deaths globally, accounting for 74% of deaths from non-communicable diseases (NCDs) or chronic diseases annually. There was a report of 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the increasing occurrence of cancer is fueling the expansion of the single-photon emission computed tomography (SPECT) market.

Which Primary Segments of the Single-Photon Emission Computed Tomography (SPECT) Market Are Driving Growth and Industry Transformations?

The single-photon emission computed tomography (spect)market covered in this report is segmented –

1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems

2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes

3) By Application: Oncology, Cardiology, Neurology, Other Applications

4) By End User: Hospitals, Diagnostic Centers, Other End User

Subsegments:

1) By Hybrid SPECT Systems: SPECT Or CT Systems, SPECT Or MRI Systems

2) By Standalone SPECT Systems: Single-Head SPECT Systems, Multi-Head SPECT Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9960&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Single-Photon Emission Computed Tomography (SPECT) Market?# Market?

North America was the largest region in the single-photon emission computed tomography (SPECT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the single-photon emission computed tomography (SPECT) market report during the forecast period. The regions covered in the single-photon emission computed tomography (spect) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Single-Photon Emission Computed Tomography (SPECT) Market?

Significant corporations in the Single-photon emission computed tomography (SPECT) market are pioneering inventive products, namely, portable gamma cameras, to augment market revenue. The portable gamma camera’s clinical trials reflect technological improvements intended to broaden SPECT imaging’s applicability, versatility, and accessibility across numerous healthcare contexts. In June 2023, for instance, Serac Imaging, a UK-based molecular imaging firm, released a high-resolution hybrid gamma optical camera that is portable. This device is meant to complement existing technology used in nuclear medicine departments, with the goal of streamlining workflows and increasing capacity.

View the full report here:

https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

What Parameters Are Used to Define the Single-Photon Emission Computed Tomography (SPECT) Market?

Single-photon emission computed tomography (SPECT) is a medical imaging technique that uses radioactive tracers and gamma rays to produce 3D images of internal organs and tissues. The tracer can be detected by a gamma camera by emitting gamma rays, allowing for non-invasive and detailed imaging of a patient’s internal structure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9960

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model